Skip to main content

The Emerging Role of Blood-based Biomarkers in Alzheimer's Disease

On-demand Webinar:

 

The objectives of this webinar include:

 

• A discussion of the current opportunities and challenges in diagnosing Alzheimer's disease

 

• A discourse on the emerging role of blood-based biomarkers (eg, P-tau, A β42/A β40, NfL) in Alzheimer's disease screening and monitoring

 

• An exploration of emerging treatments and new diagnostic pathways for Alzheimer's disease

 

•Q&A

 

P.A.C.E. credits will be available to participating laboratory professionals who attend the webinar and complete the post evaluation

 

P.A.C.E. post-evaluation link

 

When: 

Mar 29, 2022

Time: 

12:00 PM ET

Location: 

Virtual

Presenter: 

Dr Stephen Salloway & Dr Michael Racke and moderated by Gabriele Olla

Stephen P. Salloway, MD, MS

Michael K. Racke, MD